Ultrasensitive Profiling of Extracellular Vesicles by a Microbead- and Aptamer-Enhanced Thermophoretic Assay for Monitoring Therapeutic Responses.
Sign Up to like & getrecommendations! Published in 2025 at "Analytical chemistry"
DOI: 10.1021/acs.analchem.5c06434
Abstract: Longitudinal monitoring of therapeutic responses is essential for optimizing treatment strategies and improving outcomes in cancer patients. Profiling tumor-derived extracellular vesicles (tEVs) can provide critical information for effective and timely treatment monitoring. Here, we report… read more here.
Keywords: extracellular vesicles; monitoring therapeutic; microbead aptamer; monitoring ... See more keywords
Potential to Use Fingerprints for Monitoring Therapeutic Levels of Isoniazid and Treatment Adherence
Sign Up to like & getrecommendations! Published in 2022 at "ACS Omega"
DOI: 10.1021/acsomega.2c01257
Abstract: A fingerprint offers a convenient, noninvasive sampling matrix for monitoring therapeutic drug use. However, a barrier to widespread adoption of fingerprint sampling is the fact that the sample volume is uncontrolled. Fingerprint samples (n =… read more here.
Keywords: fingerprint; sample volume; treatment; monitoring therapeutic ... See more keywords
Monitoring Therapeutic Responses to Silicified Cancer Cell Immunotherapy Using PET/MRI in a Mouse Model of Disseminated Ovarian Cancer
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms231810525
Abstract: Current imaging approaches used to monitor tumor progression can lack the ability to distinguish true progression from pseudoprogression. Simultaneous metabolic 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) positron emission tomography (PET) and magnetic resonance imaging (MRI) offers new opportunities to… read more here.
Keywords: pet mri; monitoring therapeutic; immunotherapy; therapeutic responses ... See more keywords